News Bruker Corporation

Stocks

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 10/07/2026 BST			5-day change	1st Jan Change
60.06 ^USD	-0.86%		-2.56%	+27.49%

06-08	Bruker Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 11:40 AM
06-04	Bruker Corporation Showcases Expanding Microbiology and Infection Diagnostics Portfolio at ASM Microbe 2026	CI

All News

Mentions Relevance

06-08	Bruker Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 11:40 AM
06-04	Bruker Corporation Showcases Expanding Microbiology and Infection Diagnostics Portfolio at ASM Microbe 2026	CI
06-04	Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026	BU
06-02	Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry	BU
06-02	Bruker Corporation Launches New Timsmrms Mass Spectrometry Platform for Ultra-Complex Mixture Applications in the Energy Industry	CI
06-02	BofA Securities Adjusts Bruker Price Target to $65 From $49	MT
06-02	Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis	AQ
06-01	Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology	BU
06-01	Bruker Corporation Launches Novel Mass Spectrometry Systems and Advances in 4D Proteomics and Metabolomics	CI
05-27	Bruker Corporation - Champalimaud Foundation's Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI	AQ
05-26	Bruker Corporation Commissions Novel Biospec 18 Tesla Preclinical Mri At Champalimaud Foundation	CI
05-26	Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI	BU
05-13	Bruker Corporation announces Quarterly dividend, payable on July 07, 2026	CI
05-08	Bruker : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
05-07	UBS Adjusts Price Target on Bruker to $45 From $40, Maintains Neutral Rating	MT
05-06	Bruker Corporation, Q1 2026 Earnings Call, May 06, 2026
05-06	Bruker : Q1 2026 Earnings Webcast (Presentation)	PU
05-06	Bruker Q1 Adjusted Earnings Fall, Revenue Rises; Maintains Fiscal 2026 Outlook	MT
05-06	(BRKR) Bruker Expects 2026 Revenue Range $3.57B - $3.6B, vs. FactSet Est of $3.58B	MT
05-06	(BRKR) Bruker Expects 2026 Adjusted EPS Range $2.10 - $2.15, vs. FactSet Est of $2.11	MT
05-06	Earnings Flash (BRKR) Bruker Corporation Reports Q1 Revenue $823.4M, vs. FactSet Est of $795.6M	MT
05-06	Earnings Flash (BRKR) Bruker Corporation Posts Q1 Adjusted EPS $0.31 per Share, vs. FactSet Est of $0.23	MT
05-06	Bruker: Q1 Earnings Snapshot	AQ
05-06	Bruker Reports First Quarter 2026 Financial Results	BU
05-06	Bruker Corporation Reconfirms Earnings Guidance for the Fiscal Year 2026	CI